Efficacy of high-dose versus standard-dose influenza vaccine in older adults

New England Journal of Medicine

Volumn 371, Issue 7, 2014, Pages 635-645

  DiazGranados, Carlos A ^a   Dunning, Andrew J ^a   Kimmel, Murray ^d   Kirby, Daniel ^a   Treanor, John ^e   Collins, Avi ^b   Pollak, Richard ^f   Christoff, Janet ^a   Earl, John ^h   Landolfi, Victoria ^a   Martin, Earl ^g   Gurunathan, Sanjay ^a   Nathan, Richard ⁱ   Greenberg, David P ^a,c   Tornieporth, Nadia G ^a   Decker, Michael D ^a,j   Talbot, H Keipp ^k  

^a SANOFI PASTEUR   (France)

^b ReSearch Pharmaceutical Services   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Accelovance Inc   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f Endeavor Clinical Trials PA   (United States)

^g Martin Diagnostic Clinic   (United States)

^h PMG Research of Hickory   (United States)

ⁱ Idaho Falls Infectious Diseases and Snake River Research ^*  (United States)

^j VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INACTIVATED VACCINE; VIRUS ANTIBODY;

ABDUCENS NERVE PARALYSIS; ACUTE DISSEMINATED ENCEPHALOMYELITIS; AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HYPOVOLEMIC SHOCK; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE SMEAR; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE DRUG DOSE; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; INFLUENZA; INTENTION TO TREAT ANALYSIS; ORTHOMYXOVIRUS;

AGED; ANTIBODIES, VIRAL; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTENTION TO TREAT ANALYSIS; MALE; ORTHOMYXOVIRIDAE; VACCINES, INACTIVATED;

EID: 84906232635     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1315727     Document Type: Article

References (31)

1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;?289:?179-86. (Pubitemid 36068705)
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;?292:?1333-40. (Pubitemid 39223224)
3. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59 (RR-8):1-62. [Errata, MMWR Recomm Rep 2010;?59:?993, 1147.]
4. Palache A. Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies. Vaccine 2011;?29:?9459-66.
5. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994;?272:?1661-5. (Pubitemid 24359136)
6. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995;?123:?518-27.
7. Praditsuwan R, Assantachai P, Wasi C, Puthavatana P, Kositanont U. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai 2005;?88:?256-64. (Pubitemid 40813164)
8. Couch RB, Keitel WA, Cate TR. Improvement of inactivated influenza virus vaccines. J Infect Dis 1997;176:Suppl 1:S38-44.
9. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009;200:172-80.
10. Govaert TM, Dinant GJ, Aretz K, Knottnerus JA. The predictive value of influenza symptomatology in elderly people. Fam Pract 1998;?15:?16-22. (Pubitemid 28098380)
11. Talbot HK, Falsey AR. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis 2010;50:747-51.
12. De Villiers PJ, Steele AD, Hiemstra LA, et al. Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older. Vaccine 2009;28:228-34.
13. Mäkelä MJ, Pauksens K, Rostila T, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect 2000;?40:?42-8. (Pubitemid 30157772)
14. Kendal AP, Pereira MS, Skehel JJ. Hemagglutination inhibition. In: Kendal AP, Pereira MS, Skehel JJ, eds. Concepts and procedures for laboratory-based influenza surveillance. Atlanta: Centers for Disease Control and Prevention, 1982: B19-B35.
15. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;?17:?857-72. (Pubitemid 28185165)
16. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998;?17:?873-90. [Erratum, Stat Med 1999;?18:?1293.] (Pubitemid 28185166)
17. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005;?165:?265-72. (Pubitemid 40216277)
18. McElhaney JE. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 2005;23:Suppl 1:S10-S25.
19. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:36-44. [Erratum, Lancet Infect Dis 2012;?12:?655.]
20. Banzhoff A, Pellegrini M, Del Giudice G, Fragapane E, Groth N, Podda A. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis. Influenza Other Respir Viruses 2008;2:243-9.
21. Mannino S, Villa M, Apolone G, et al. Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol 2012;176:527-33.
22. Skowronski DM, De Serres G, Janjua NZ, Hottes TS. Re: "effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy". Am J Epidemiol 2013;177:593-4.
23. McElhaney JE, Beran J, Devaster JM, et al. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis 2013;13:485-96.
24. Atmar RL, Patel SM, Keitel WA. Intanza: a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines 2010;9:1399-409.
25. DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012;31:49-57.
26. Tsang P, Gorse GJ, Strout CB, et al. Immunogenicity and safety of Fluzone intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial. Vaccine 2014;32:2507-17.
27. Update: influenza activity - United States, 2011-12 season and composition of the 2012-13 influenza vaccine. MMWR Morb Mortal Wkly Rep 2012;61:414-20.
28. Estimated influenza illnesses and hospitalizations averted by influenza vaccination - United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2013;62:997-1000.
29. Influenza activity - United States, 2012-13 season and composition of the 2013-14 influenza vaccine. MMWR Morb Mortal Wkly Rep 2013;62:473-9.
30. Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season. Wkly Epidemiol Rec 2013;88:101-14.
31. DiazGranados CA, Dunning AJ, Jordanov E, Landolfi V, Denis M, Talbot HK. High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season. Vaccine 2013;31:861-6.